RE:Share Price and Perception IssuesYou prove nothing with a 3 year old list other than that Cantech can't pick biotech stocks. Only one out of 10 managed a slight rise.
In the US. there are approximately 1000 microcap biotech stocks. So some made it to the Naz, who cares. The failure rate is bound to be high there too.